Science Explorer Back to mapMap
Discussion
Researcher · Krankenhaus der Elisabethinen · Austria

Michael Girschikofsky

Michael Girschikofsky publishes mostly in Hematology, Genetics and Oncology, on topics such as Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment and Multiple Myeloma Research and Treatments.

ORCID 0000-0003-3270-411X OpenAlex
World rank
#538,033
of 7,710,434 ranked researchers
Rank in Austria
#3,506
of 43,330
Works
85
Citations
5.2k
Citations per work
60.8
h-index
26
i10-index 34Top 16% in Hematology
Michael Girschikofsky

What does Michael Girschikofsky research?

Michael Girschikofsky's work is mostly in Medicine (60%), Immunology and Microbiology (6%).

Health Sciences: 51 works · 59.7% of their workMedicine: 51 works · 59.7% of their workHematology: 27 works · 31.3% of their workGenetics: 10 works · 12.0% of their workOncology: 6 works · 7.6% of their workInfectious Diseases: 4 works · 4.4% of their workRheumatology: 4 works · 4.4% of their workEverything else: 29 works · 34.3% of their workLife Sciences: 5 works · 6.0% of their workImmunology and Microbiology: 5 works · 6.0% of their workImmunology: 5 works · 6.0% of their workTHEIR WORKMichaelGirschikofsky85works
Life Sciences6%Health Sciences60%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine5159.7%
  2. Everything else2934.3%
    1. Immunology and Microbiology56.0%
  1. 1Hematology31% of their works
  2. 2Genetics12% of their works
  3. 3Oncology8% of their works
  4. 4Immunology6% of their works
  5. 5Rheumatology4% of their works
  6. 6Infectious Diseases4% of their works

Research topics

Which keywords describe Michael Girschikofsky's research?

The keywords of their largest research topics: Prognostic Factors, Acute Myeloid Leukemia, AML, Minimal Residual Disease, JAK2 Mutation, Myelofibrosis, Diagnosis Criteria and International Myeloma Working Group.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Prognostic Factors623 topics
  2. AML451 topic
  3. Acute Myeloid Leukemia451 topic
  4. Minimal Residual Disease222 topics
  5. JAK2 Mutation181 topic
  6. Myelofibrosis181 topic
  7. Diagnosis Criteria151 topic
  8. International Myeloma Working Group151 topic
  9. BCR-ABL101 topic
  10. Chronic Lymphocytic Leukemia101 topic
  11. Fusion Genes101 topic
  12. Genomic Aberrations101 topic
  13. Hypereosinophilic Syndrome101 topic
  14. Imatinib101 topic
  15. Erdheim-Chester Disease91 topic
  16. Langerhans Cell Histiocytosis91 topic
  17. Acute Lymphoblastic Leukemia71 topic
  18. Childhood Cancer71 topic

Where does Michael Girschikofsky work?

Michael Girschikofsky's main affiliation in the publication record is Krankenhaus der Elisabethinen, Austria.

How many publications and citations does Michael Girschikofsky have?

OpenAlex counts 85 works and 5,166 citations for Michael Girschikofsky, an h-index of 26, ranking #538,033 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Michael Girschikofsky. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.